reports
Farmers National Banc Corp. Announces Strong Results for First Quarter...
CANFIELD, Ohio--(BUSINESS WIRE)-- Farmers National Banc Corp. (“Farmers” or the “Company”) (NASDAQ: FMNB) reported net income of $11.2 million, or $0.30 per diluted share, for the three months ended March 31, 2024, compared to $7.1 million, or $0.19 per diluted share, for the three months ended March 31, 2023. Net income for the first quarter of 2024 included a pretax item of $2.1 million for the loss on the sale of investment securities. Excluding this item (non-GAAP), net income for the first quarter of 2024 was $12.9 million, or $0.34 per diluted share. Kevin J. Helmick, President and CEO...
Carpenter Technology Declares Quarterly Cash Dividend
Carpenter Technology Declares Quarterly Cash Dividend PHILADELPHIA, April 12, 2024 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share of common stock, payable June 6, 2024, to shareholders of record on April 23, 2024. The ex-dividend date (the date the common stock trades without the dividend) is April 22, 2024. About Carpenter Technology Carpenter Technology Corporation is a recognized leader in high-performance specialty alloy-based materials and process solutions for critical...
Carpenter Technology Announces Conference Call and Webcast
Carpenter Technology Announces Conference Call and Webcast PHILADELPHIA , April 05, 2024 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Wednesday, May 1, 2024 at 10:00 a.m. ET to discuss the results of operations for the third quarter of fiscal year 2024, ended March 31, 2024. The call and webcast will follow the release of third quarter fiscal 2024 financial results before the market opens on Wednesday, May 1, 2024. Conference Call and Webcast Details What: Carpenter Technology Third Quarter Fiscal 2024 Conferenc...
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance ...
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today issued its fourth annual Environmental, Social, and Governance (ESG) report. This year’s report highlights the strength of the Company’s corporate responsibility structure including increased efforts towards transparency in our environmental reporting, our deep commitment to ensuring broad and equitable access...
Amicus Therapeutics to Present at Upcoming Investor Conferences in Mar...
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024 PRINCETON, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in March. Cowen 44th Annual Health Care Conference in Boston, MA, on Monday, March 4, 2024, at 11:10 a.m. E.T.Leerink Partners 2024 Global Biopharma Conference in Miami, FL on Monday, March 11, 2024, at 3:20 p.m. E.T. A live audio webcast of each presentation can also be accessed via the investors section of the A...
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Cor...
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates 2023 Total Revenue of $399.4M, a 21% Increase Year-over-Year Strong Patient Demand Continues for Pombiliti™ + Opfolda™ in the U.S., U.K., and Germany Projecting 2024 Galafold® Revenue Growth of 11-16% at CER Anticipating Full-Year Non-GAAP Profitability in 2024 Conference Call and Webcast Today at 8:30 a.m. ET PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases,...
Farmers National Banc Corp. Declares Quarterly Cash Dividend
CANFIELD, Ohio--(BUSINESS WIRE)-- On February 27, 2024, the Board of Directors of the Farmers National Banc Corp. (NASDAQ: FMNB) declared a quarterly cash dividend of $0.17 per share. The common stock cash dividend will have a record date of March 8, 2024, and is payable to shareholders on March 29, 2024. ABOUT FARMERS NATIONAL BANC CORP. Founded in 1887, Farmers National Banc Corp. is a diversified financial services company headquartered in Canfield, Ohio, with $5.1 billion in banking assets. Farmers National Banc Corp.’s wholly-owned subsidiaries are comprised of The Farmers National Ba...
Amicus Therapeutics to Announce Full Year 2023 Financial Results on Fe...
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024 PRINCETON, N.J., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Wednesday, February 28, 2024, at 8:30 a.m. ET to discuss financial results for the full-year ended December 31, 2023. Participants and investors interested in accessing the call by phone will need to register using the . After registering, all phone participants will receive a dial-in number along with a personal PIN to access the ev...
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombilit...
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™ - Award Recognizes Approval of Amicus Therapeutics’ Two-component Therapy for the Treatment of Late-onset Pompe Disease - PRINCETON, N.J., Feb. 08, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: FOLD), today announced that WORLDSymposium™ has awarded Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) the 2024 New Treatment Award, which recognizes important achievements in advancing treatments for lysosomal diseases which have attai...
Amicus Therapeutics Announces Presentations and Posters at the 20th An...
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024 PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: FOLD), today announced that one oral presentation and 11 posters across its development programs will be included at the , being held February 4-9, 2024 in San Diego, CA. Oral Platform Presentation: Fabry Disease: Abstract Title: Trial in progress: An open-label study (AT1001-025) to evaluate the safety and pharmacokinetics of migalastat in patients with Fabry disease and amenable GLA variants and severe renal impairment or e...
Carpenter Technology Reports Second Quarter Fiscal Year 2024 Results
Carpenter Technology Reports Second Quarter Fiscal Year 2024 Results PHILADELPHIA, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) (the “Company”) today announced financial results for the fiscal second quarter ended December 31, 2023. For the quarter, the Company reported net income of $42.7 million, or $0.85 earnings per diluted share. Second Quarter Fiscal Year 2024 Highlights Reported earnings per diluted share of $0.85 Achieved operating income of $69.8 million, up from $69.0 million in the previous quarter, completing the second most profitable f...
Farmers National Banc Corp. Reports Solid Results for Fourth Quarter o...
CANFIELD, Ohio--(BUSINESS WIRE)-- Farmers National Banc Corp. (“Farmers” or the “Company”) (NASDAQ: FMNB) today announced net income of $14.6 million, or $0.39 per diluted share, for the three months ended December 31, 2023, compared to $13.4 million, or $0.39 per diluted share, for the three months ended December 31, 2022. Net income for the fourth quarter of 2023 included pretax items of $452,000 for acquisition related costs, a gain of $915,000 on the sale of commercial loans, $1.0 million in expense for severance/contract payouts for staff resignations, and combined net losses of $217,000 ...
Carpenter Technology Declares Quarterly Cash Dividend
Carpenter Technology Declares Quarterly Cash Dividend PHILADELPHIA, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share of common stock, payable March 7, 2024, to shareholders of record on January 30, 2024. The ex-dividend date (the date the common stock trades without the dividend) is January 29, 2024. About Carpenter Technology Carpenter Technology Corporation is a recognized leader in high-performance specialty alloy-based materials and process solutions for crit...
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024...
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook 2023 Total Revenue of ~$399.4M, a 21% Increase Year-Over-Year >2,400 People Living with Fabry Disease on Galafold® Following a Year of Increased Demand Expecting 2024 Galafold Revenue Growth of 11-16% at CER Successful Launches of Pombiliti™ + Opfolda™ Underway in the U.S., U.K., and Germany PRINCETON, N.J., Jan. 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today provided...
Carpenter Technology Announces Conference Call and Webcast
Carpenter Technology Announces Conference Call and Webcast PHILADELPHIA, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Thursday, January 25, 2024 at 10:00 a.m. ET to discuss the results of operations for the second quarter of fiscal year 2024, ended December 31, 2023. The call and webcast will follow the release of second quarter fiscal 2024 financial results before the market opens on Thursday, January 25, 2024. Conference Call and Webcast Details What: Carpenter Technology Second Quarter Fiscal 2024 Confe...
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthca...
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference PRINCETON, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley Campbell, President and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 8, 2024, at 2:15 p.m. PT. A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at . About Amicus Therapeutics Amicus Therapeutics (Nasdaq: FOLD) is a global, p...
- MarketLine Department
Gloria Material Technology Corporation - Company Profile and SWOT Anal...
Summary Gloria Material Technology Corporation - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Gloria Material Technology Corp (GMTC), is a manufacturer of special steel material. It manufactures and distributes special alloy materials such as super alloy, high speed steel,...
Amicus Therapeutics Congratulates Executive Chairman John F. Crowley o...
Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIO Crowley to Step Down from Amicus Board of Directors in March 2024 and Become Amicus Chairman Emeritus Michael Raab, Current Lead Independent Director, to Become Chairman of Amicus Board of Directors PRINCETON, N.J., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Executive Chairman of Amicus Therapeutics, will step down from the Amicus Board of Directors and assume the role of President and Chief Executive Officer...
Farmers National Banc Corp. Declares Quarterly Cash Dividend
CANFIELD, Ohio--(BUSINESS WIRE)-- On November 28, 2023, the Board of Directors of the Farmers National Banc Corp. (NASDAQ: FMNB) declared a quarterly cash dividend of $0.17 per share. The common stock cash dividend will have a record date of December 11, 2023, and is payable to shareholders on December 29, 2023. ABOUT FARMERS NATIONAL BANC CORP. Founded in 1887, Farmers National Banc Corp. is a diversified financial services company headquartered in Canfield, Ohio, with $5.0 billion in banking assets. Farmers National Banc Corp.’s wholly-owned subsidiaries are comprised of The Farmers Nati...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.